References
- Gerbershagen HJ, Aduckathil S, van Wijck AJM, et al. Pain intensity on the first day after surgery: a prospective cohort study comparing 179 surgical procedures. Anesthesiology. 2013;118(4):934–944.
- American Society of Anesthesiologists Task Force on Acute Pain Management. Practice guidelines for acute pain management in the perioperative setting: an updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management. Anesthesiology. 2012;116:248–273.
- McNicol ED, Ferguson MC, Hudcova J. Patient controlled opioid analgesia versus non-patient controlled opioid analgesia for postoperative pain. Cochrane Database Syst Rev. 2015;(6):CD003348.
- Schwenkglenks M, Gerbershagen HJ, Taylor RS, et al. Correlates of satisfaction with pain treatment in the acute postoperative period: results from the international PAIN OUT registry. Pain. 2014;155(7):1401–1411.
- Macintyre PE. Safety and efficacy of patient-controlled analgesia. Br J Anaesth. 2001;87(1):36–46.
- Moss J. Reducing errors during patient-controlled analgesia therapy through failure mode and effects analysis. Jt Comm J Qual Patient Saf. 2010;36(8):359–364.
- Vicente KJ, Kada-Bekhaled K, Hillel G, et al. Programming errors contribute to death from patient-controlled analgesia: case report and estimate of probability. Can J Anesth/J Can Anesth. 2003;50(4):328–332.
- Power I, McCormack JG. Advances in patient-controlled analgesia: the role of fentanyl ITS. Med Devices (Auckl). 2008;1:49–57.
- Viscusi ER, Reynolds L, Chung F, et al. Patient-controlled transdermal fentanyl hydrochloride vs intravenous morphine pump for postoperative pain: a randomized controlled trial. JAMA. 2004;291(11):1333–1341.
- Minkowitz HS. A review of sufentanil and the sufentanil sublingual tablet system for acute moderate to severe pain. Pain Manag. 2015;5(4):237–250.
- Frampton JE. Sublingual sufentanil: a review in acute postoperative pain. Drugs. 2016;76(6):719–729.
- Willsie SK, Evashenk MA, Hamel LG, et al. Pharmacokinetic properties of single- and repeated-dose sufentanil sublingual tablets in healthy volunteers. Clin Ther. 2015;37(1):145–155.
- van de Donk T, Ward S, Langford R, et al. Pharmacokinetics and pharmacodynamics of sublingual sufentanil for postoperative pain treatment. Anaesthesia. 2018;73(2):231–237.
- Porela-Tiihonen S, Kokki M, Kokki H. Sufentanil sublingual formulation for the treatment of acute, moderate to severe postoperative pain in adult patients. Expert Rev Neurother. 2017;17(2):101–111.
- European Medicines Agency (EMA) [Internet]. Zalviso: sufentanil. Summary of product characteristics; 2017 [cited 2019 June 14]. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002784/human_med_001916.jsp&mid=WC0b01ac058001d124
- Minkowitz HS, Singla NK, Evashenk MA, et al. Pharmacokinetics of sublingual sufentanil tablets and efficacy and safety in the management of postoperative pain. Reg Anesth Pain Med. 2013;38(2):131–139.
- Ringold FG, Minkowitz HS, Gan TJ, et al. Sufentanil sublingual tablet system for the management of postoperative pain following open abdominal surgery: a randomized, placebo-controlled study. Reg Anesth Pain Med. 2015;40(1):22–30.
- Jove M, Griffin DW, Minkowitz HS, et al. Sufentanil sublingual tablet system for the management of postoperative pain after knee or hip arthroplasty: a randomized, placebo-controlled study. Anesthesiology. 2015;123(2):434–443.
- Melson TI, Boyer DL, Minkowitz HS, et al. Sufentanil sublingual tablet system vs. intravenous patient-controlled analgesia with morphine for postoperative pain control: a randomized, active-comparator trial. Pain Pract. 2014;14(8):679–688.
- WHO. Cancer: WHO's cancer pain ladder for adults [Internet]; 2017; [cited 2019 June 14]. Available from: http://www.who.int/cancer/palliative/painladder/en/
- Gerbershagen HJ, Pogatzki-Zahn E, Aduckathil S, et al. Procedure-specific risk factor analysis for the development of severe postoperative pain. Anesthesiology. 2014;120(5):1237–1245.
- Hinrichs M, Weyland A, Bantel C. Piritramide: a critical review. Schmerz. 2017;31(4):345–352.
- Rüsch D, Becke K, Eberhart LH, et al. Postoperative nausea and vomiting (PONV) – recommendations for risk assessment, prophylaxis and therapy – results of an expert panel meeting. Anästhesiol Intensivmed Notfallmed Schmerzther. 2011;46(03):158–170.
- Scardino M, D'Amato T, Martorelli F, et al. Sublingual sufentanil tablet system Zalviso for postoperative analgesia after knee replacement in fast track surgery: a pilot observational study. J Exp Orthop. 2018;5(1):8.
- Leykin Y, Laudani A, Busetto N, et al. Sublingual sufentanil tablet system for postoperative analgesia after gynecological surgery. Minerva Med. 2019;110(3):209–215.
- Suvarna VR. Real world evidence (RWE) – are we (RWE) ready? Perspect Clin Res. 2018;9(2):61–63.
- Kim HS, Lee S, Kim JH. Real-world evidence versus randomized controlled trial: clinical research based on electronic medical records. J Korean Med Sci. 2018;33(34):e213.